NEW YORK, May 12 (GenomeWeb News) - Bruker Biosciences CEO Frank Laukien bought more than $666,000 worth of his company's stock since Tuesday, sending the shares up 6.7 percent to $3.83 in mid-afternoon trading today.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.